» Articles » PMID: 2326636

A Class I Antigen, HLA-G, Expressed in Human Trophoblasts

Overview
Journal Science
Specialty Science
Date 1990 Apr 13
PMID 2326636
Citations 346
Authors
Affiliations
Soon will be listed here.
Abstract

The alpha chain of the human histocompatibility antigen HLA-G was identified as an array of five 37- to 39-kilodalton isoforms by the use of two-dimensional gel electrophoresis. Both cell-associated and secreted HLA-G antigens are prominent in first trimester villous cytotrophoblasts and are greatly reduced in third trimester cytotrophoblasts. Allelic variation was not detected, an indication that HLA-G is not obviously polymorphic in cytotrophoblasts. Among the following choriocarcinoma cell lines studied, HLA-G is expressed in JEG but not in Jar or BeWo. Expression of endogenous HLA-G genes has not been found in normal lymphoid cells. Thus, HLA-G is subject to both cell type-specific and developmental regulation and is expressed in early gestation human cytotrophoblasts.

Citing Articles

Expression of NKp46 and other activating inhibitory receptors on uterine endometrial NK cells in females with various reproductive failures: A review.

Mai C, Fukui A, Saeki S, Takeyama R, Yamaya A, Shibahara H Reprod Med Biol. 2025; 24(1):e12610.

PMID: 39807425 PMC: 11725765. DOI: 10.1002/rmb2.12610.


Association of HLA-G Expression, Its Genetic Variants and Related Neuro-Immunomodulation with Characteristics of Bladder Carcinoma.

Durmanova V, Mikolaskova I, Zsemlye E, Ocenasova A, Bandzuchova H, Suchankova M Cancers (Basel). 2024; 16(22).

PMID: 39594832 PMC: 11593171. DOI: 10.3390/cancers16223877.


Ralationship between polymorphisms and diplotypes of HLA-G 3'UTR and fetuses with abnormal chromosomes or unexplained pregnancy loss (UPL).

Xu D, Zhu Y, Wang J, Guan H, Shen X Hum Genomics. 2024; 18(1):126.

PMID: 39551809 PMC: 11572094. DOI: 10.1186/s40246-024-00695-5.


HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance.

Branz A, Matek C, Lange F, Bahlinger V, Klumper N, Holzel M Front Immunol. 2024; 15:1478196.

PMID: 39469714 PMC: 11513269. DOI: 10.3389/fimmu.2024.1478196.


A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapy.

Gilger B, Hasegawa T, Sutton R, Bower J, Li C, Hirsch M Mol Ther. 2024; 32(11):4006-4020.

PMID: 39245940 PMC: 11573577. DOI: 10.1016/j.ymthe.2024.09.007.